ClinicalTrials.govpublic full text
Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade
melanoma (skin cancer), nsclc (non-small cell lung cancer)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 346913
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.